Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 40.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 3.00 (7.50%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 41.00
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

29 Dec 2023 12:00

RNS Number : 6201X
Frontier IP Group plc
29 December 2023

29 December 2023

Frontier IP Group plc

("Frontier IP" or the "Company")

Total Voting Rights

Frontier IP, a specialist in commercialising intellectual property, announces that the issued share capital of the Company at the date of this announcement comprises 56,166,946 ordinary shares with one voting right per share ('Ordinary Shares'). The Company does not hold any Ordinary Shares in treasury. The total number of Ordinary Shares and voting rights in the Company is therefore 56,166,946.

The above figure of 56,166,946 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

ENQUIRIES

Frontier IP Group Plc

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

Company website: www.frontierip.co.uk

T: 020 3968 7815 neil@frontierip.co.uk

M: 07464 546 025

andrew.johnson@frontierip.co.uk

Allenby Capital Limited (Nominated Adviser)

Nick Athanas / George Payne

T: 0203 328 5656

Singer Capital Markets (Broker)

Harry Gooden / James Fischer

T: 0207 496 3000

ABOUT FRONTIER IP

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TVRBGBDDXGDDGXB
Date   Source Headline
24th Mar 20174:33 pmRNSHolding(s) in Company
23rd Mar 20173:27 pmRNSHolding(s) in Company
23rd Mar 20173:26 pmRNSHolding(s) in Company
23rd Mar 20173:25 pmRNSHolding(s) in Company
17th Mar 201712:10 pmRNSPlacing to raise £3 million
8th Feb 20177:00 amRNSChange of Adviser
23rd Dec 201611:45 amRNSResult of AGM
7th Dec 20167:00 amRNSNew Portfolio Company - Tarsis Technology Limited
28th Nov 20167:00 amRNSPosting of Annual Report and Notice of AGM
21st Nov 20167:00 amRNSAudited final results for year ended 30 June 2016
4th Nov 201611:00 amRNSALUSID Wins Prestigious IChemE Award
14th Sep 201611:50 amRNSAgreement with FCT, Universidade NOVA de Lisboa
5th Sep 20167:00 amRNSNandi Proteins Participant in £1m Funding Award
27th Apr 20167:00 amRNSex scientia Limited - Partnership with Evotec AG
11th Apr 20163:31 pmRNSHolding(s) in Company
7th Apr 20167:05 amRNSHolding(s) in Company
7th Apr 20167:00 amRNSGrant of Options
31st Mar 20168:30 amRNSHolding(s) in Company
30th Mar 20169:00 amRNSHolding(s) in Company
24th Mar 20167:00 amRNSEquity Placing raising £1.0M & Total Voting Rights
9th Mar 20167:00 amRNSHalf-year results for the 6 months to 31 Dec 2015
7th Mar 20167:00 amRNSNandi Proteins Ltd: Further Successful Fundraising
8th Feb 20167:00 amRNSAgreement with first Portuguese University
21st Dec 201512:16 pmRNSResult of AGM
7th Dec 20157:00 amRNSAlusid wins prestigious Product of the Year award
1st Dec 20157:00 amRNSHolding(s) in Company
30th Nov 20154:20 pmRNSHolding(s) in Company
26th Nov 20157:00 amRNSPosting of Annual Report and Notice of AGM
19th Nov 20157:00 amRNSPreliminary results for year ended 30 June 2015
27th Oct 20157:00 amRNSPortfolio Company Fundraising - PulsiV Solar Ltd
14th Sep 20157:00 amRNSHolding(s) in Company
14th Sep 20157:00 amRNSHolding(s) in Company
24th Jul 20152:18 pmRNSHolding(s) in Company
10th Jul 20158:30 amRNSHolding(s) in Company
14th Apr 20157:00 amRNSHolding(s) in Company
10th Apr 20157:00 amRNSPlacing of new shares
31st Mar 20157:00 amRNSHalf Yearly Report
25th Mar 201510:52 amRNSPortfolio company, Alusid - First Fundraising
11th Mar 20157:00 amRNSKey development at portfolio company PulsiV Solar
10th Mar 20157:03 amRNSHolding(s) in Company
9th Mar 20157:00 amRNSNew advisory client, Vertequip
2nd Mar 20157:00 amRNSNew portfolio company
9th Feb 20157:00 amRNSScottish Enterprise Awards
5th Feb 20157:00 amRNSKey developments at portfolio company Alusid
2nd Feb 20157:00 amRNSHolding(s) in Company
7th Jan 20157:00 amRNSPortfolio company Nandi Proteins featured on BBC
29th Dec 201411:44 amRNSResult of AGM
4th Dec 20147:00 amRNSPosting of Annual Report & Notice of AGM
1st Dec 20147:00 amRNSFinal Results
26th Nov 20147:00 amRNSNew spin-out company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.